Arkolith/Insider Trading/RNA/Form 4

Hughes Steven George

Chief Medical OfficerAvidity Biosciences, Inc. (RNA) · full profile →Form 4 · filed Aug 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.5M
Net Open-Market Flow
-$3.5M
Transactions
13
9 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 6, 2025Sell(S)18K$42.74$755K73K
Aug 6, 2025Sell(S)34K$42.74$1.5M39K
Aug 6, 2025Option exercise(M)11K$15.96$180K84K
Aug 6, 2025Sell(S)11K$42.74$482K73K
Aug 6, 2025Option exercise(M)12K$6.57$81K85K
Aug 6, 2025Sell(S)12K$42.74$527K73K
Aug 6, 2025Option exercise(M)6K$22.47$139K79K
Aug 6, 2025Sell(S)6K$42.74$264K73K
Aug 6, 2025Option exercise(M)18K$10.16$179K91K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 6, 2025Option exercise(M)11K—$073K
Aug 6, 2025Option exercise(M)12K—$052K
Aug 6, 2025Option exercise(M)6K—$074K
Aug 6, 2025Option exercise(M)18K—$075K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599901-25-000150) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML